Before forming Lux Capital, a firm focused on investments in nanotechnology and software, Josh worked in Salomon Smith Barney's Investment Banking group. Josh also worked in capital markets while at Merrill Lynch on its Financial Futures and Options/Government Strategy desk and at Prudential Securities in its Municipal Finance department.

Prior to venturing into the financial world, Josh conducted and published cutting edge AIDS/immunopathology research in Cell Vision and The Journal of Leukocyte Biology, leading medical/immunology journals.

Josh is a co-founder of and advisor to The NanoBusiness Alliance, a Senior Associate of the Foresight Institute for Nanotechnology, the Coordinator for the Institute of Molecular Manufacturing's Prize in Computational Nanotechnology, and a member of the Cognitive Science Society. Josh is a founding advisory board member of NanoMateria, a nanobio venture from Northwestern University, with the first All-Nobel Prize advisory committee.

Josh graduated with distinction from Cornell University with a B.S. in Economics and Finance. He was honored by Crain's Magazine as one of "The 40 under 40" in 2003. Josh is author of the acclaimed "Nanotech Report" and Editor of Forbes' fastest growing monthly publication, the "Forbes/Wolfe Nanotech Report."